November 10, 2016

Philip Pellett, Ph.D., appointed to lead Department of Immunology and Microbiology

Philip Pellett, Ph.D., professor of Immunology and Microbiology, has been appointed chair of the Department of Immunology and Microbiology.

Dr. Pellett had been serving as interim chair of the department since Oct. 1, 2015, and joined the School of Medicine in 2007.

He is a widely published and respected researcher who received his bachelor's degree in chemistry in 1980 from Ohio University and his doctoral degree in virology from the University of Chicago in 1986, working in the laboratory of Bernard Roizman, Sc.D.

Before joining WSU, Dr. Pellett served as chief of the Herpesvirus Section of the U.S. Centers for Disease Control and Prevention from 1986 until 2003. He was director of Herpesvirus Translational and Basic Research at the Cleveland Clinic from 2003 to 2007. He also has served as a professor of Molecular Biology and Microbiology at Case Western Reserve University, and as a professor of Molecular Medicine for the Cleveland Clinic Lerner College of Medicine at that university.

He has been an advisor and consultant to the National Institutes of Health, the U.S. Food and Drug Administration, the National Science Foundation, the director of the National Cancer Institute and the Human Herpesvirus 6 Foundation. He was chair of the Herpesvirus Study Group of the Vertebrate Virus Subcommittee of the International Committee for Taxonomy of Viruses from 2006 to 2012. Dr. Pellett serves on the editorial boards of several virology and immunology journals. He has been invited to write numerous editorial commentaries and is responsible for chapters about herpesviruses in highly regarded reference texts, including the Manual of Clinical Microbiology and Fields Virology.

Dr. Pellett's research is aimed at understanding the biology of human herpesviruses and improving clinical outcomes of infection. He studies how human cytomegalovirus remodels cells it infects, transforming them into factories that can produce an infectious virus. CMV is the leading cause of congenitally-acquired cerebral palsy and deafness, and an important cause of mental retardation, seizures, blindness and death. One in 150 children is born with the virus, and one in 750 is born with or will develop permanent disabilities caused by congenital CMV.

Subscribe to Today@Wayne

Direct to your inbox each week